WO1992000771A1 - Inhaler - Google Patents
Inhaler Download PDFInfo
- Publication number
- WO1992000771A1 WO1992000771A1 PCT/GB1991/001147 GB9101147W WO9200771A1 WO 1992000771 A1 WO1992000771 A1 WO 1992000771A1 GB 9101147 W GB9101147 W GB 9101147W WO 9200771 A1 WO9200771 A1 WO 9200771A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- substance
- presented
- cup
- storage chamber
- inhalation passage
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0065—Inhalators with dosage or measuring devices
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0065—Inhalators with dosage or measuring devices
- A61M15/0068—Indicating or counting the number of dispensed doses or of remaining doses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0065—Inhalators with dosage or measuring devices
- A61M15/0068—Indicating or counting the number of dispensed doses or of remaining doses
- A61M15/007—Mechanical counters
- A61M15/0071—Mechanical counters having a display or indicator
- A61M15/0075—Mechanical counters having a display or indicator on a disc
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06M—COUNTING MECHANISMS; COUNTING OF OBJECTS NOT OTHERWISE PROVIDED FOR
- G06M1/00—Design features of general application
- G06M1/22—Design features of general application for visual indication of the result of count on counting mechanisms, e.g. by window with magnifying lens
- G06M1/24—Drums; Dials; Pointers
- G06M1/246—Bands; Sheets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/06—Solids
- A61M2202/062—Desiccants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/06—Solids
- A61M2202/064—Powder
Definitions
- This invention relates to an inhaler, namely a device for use in delivering a dose of medicament or other substance for inhaling into the lungs.
- inhaler propels the dose of medicament in pressurised gas from an aerosol.
- this form of inhaler is becoming less popular because of environmental and other considerations.
- the delivery of some drugs in a dry, finely divided form has been shown to have certain medical advantages over other forms of delivery.
- EP 079478, EP 166294 and GB 2165159 all disclose dry powder inhalers which can be operated by one hand.
- the inhaler includes a medicament storage chamber and an inhalation passage through which air is drawn via a mouthpiece.
- a metering member provided with a metering recess transfers a dose of medicament from the storage chamber and deposits it in the inhalation chamber.
- US 2587215 also discloses dry powder inhalers with the same disadvantages as those mentioned above.
- this document also discloses an embodiment in which the metering member presents the medicament in an upwardly open dispensing cup to a mixing chamber where it is mixed with air before being sucked into an inhalation tube via a nozzle having a narrow opening. Air sucked into the inhaler passes into the inhalation tube either directly or through the mixing chamber and nozzle. Accordingly, not all the air passes over the dispensing cup. If medicament adheres to the surface of the dispensing cup but is not sucked therefrom, there will be an underdose of medicament delivered to the user.
- the metering member is a rotary sliding device journalled on a cylindrical pivot member extending from the bottom of the body of the device. Such an arrangement is susceptible to jamming due to ingress of powder between the cylindrical contacting surfaces of the pivot member and the metering member.
- a metering member including a number of tapered metering recesses which are open at top and bottom.
- finely divided medicament from a storage chamber is packed into the recesses whereupon the metering member is moved to a dispensing position in which air can be drawn through the recesses to draw out the medicament.
- This device is considerad to have a number of major shortcomings. Firstly, the metering recesses are prone to clogging. Secondly, a large amount of suction is required so that the device is unsuitable for many patients with breathing problems. Thirdly, two hands are required to operate the device.
- the aim of the present invention may be viewed as being to provide a form of inhaler for one-handed operation which is capable of administering accurate doses and avoids the risk of multiple dosing.
- a further aim is to provide an inhaler which does not require a large amount of suction for effective operation.
- the present invention provides an inhaler for delivering a substance in a finely divided form, comprising a body defining a storage chamber for the substance to be delivered and further defining an inhalation passage through which air is drawn via a mouthpiece, and a metering member operable to transfer a volumetric dose of the substance from the storage chamber to the inhalation passage, the metering member having a metering surface which is indented to provide at least one dispensing cup and being moveable between a first position in which a dispensing cup is presented to the storage chamber to receive a dose of the substance and a second position in which a dose of the substance is presented to the inhalation passage in a position which is upwardly open in use, and means for ensuring that each dispensing cup is substantially free from the substance before being presented to the storage chamber.
- the means for ensuring that each dispensing cup is substantially free from the substance before being, presented to the storage chamber may comprise an inhalation passage so formed that the dose of the substance presented to the inhalation passage is subjected to substantially the entire airflow through the inhalation passage when air is drawn through the mouthpiece. Accordingly, whether air is drawn into the inhaler through a single opening or through several openings, the airflow through the device is such that all the air flows along a single duct at the point where the dispensing cup is presented to the airflow within this duct.
- the means for ensuring that each dispensing cup is substantially free from the substance before being presented to the storage chamber may additionally or alternatively comprise means for moving the cup into a position where it is downwardly open after a dose of the substance has been presented therein to the inhalation passage and before the cup is again presented to the storage chamber.
- the means for ensuring that each dispensing cup is substantially free from the substance before being presented to the storage chamber may also consist of or additionally comprise means for dislodging any additional substance from the cup after a dose of the substance has been presented therein to the inhalation passage and before the cup is again presented to the storage chamber.
- Such dislodging means may comprise resilient wiping means. The provision of such dislodging means ensures that the cup is cleaned prior to re ⁇ filling, and thereby prevents a build-up of adherent material with repeated refills.
- the metering member is resiliently biased into contact with a seat and is moveable while in contact with the seat. More preferably, the metering member is rotatable while in contact with said seat.
- the metering member may include a frusto-conical side wall containing the dispensing cup.
- a side wall can include a plurality of spaced-apart dispensing cups.
- the use of the frusto-conical shape in the wall of the metering member containing the dispensing cups allows a good seal to be obtained between the metering member and a seat against which the frusto-conical wall mates. Accordingly, either rigid or semi-rigid plastics materials can be used, and the appropriate shapes can be manufactured with relatively undemanding tolerances.
- the frusto-conical shape also makes it possible to form the metering member in such manner that it occupies relatively little space, so that the inhalation passage can be shorter than in many prior inhalers, reducing the amount of suction required from the patient.
- the longitudinal axis of said frusto-conical wall lies, when the inhaler is held in its normal in-use position, between vertical and an angle of 60° to the vertical. More preferably, such axis lies at an angle of about 45° to the vertical.
- an inhaler in accordance with the present invention includes a chamber for containing moisture- absorbent material, with which chamber the or each dispensing cup is moveable into register after a dose of the substance has been presented to the inhalation passage and before the cup is again presented to the storage chamber.
- the empty cup can be dried prior to filling to reduce adhesion of the substance in the cup.
- the filled dispensing cup may also move into register with the same or another chamber for moisture-absorbent material as it travels from the storage chamber to the inhalation passage. This could assist in preventing migration of moisture from the inhalation passage into the storage chamber.
- the inhaler preferably includes display means which is indexed in association with the metering member to display an item of information to the user.
- the display means may comprise counter means for counting the number of times which a dispensing cup has been presented to the inhalation passage, and/or the number of doses remaining to be so presented.
- a frusto- conical shaped metering member is particularly advantageous - in allowing greater manufacturing tolerances than would be possible with other configurations. If the metering member has a flat metering surface, as is the case in the above- described embodiment of US 2587215, then it is necessary to provide a separate axle or spigot journalled on a part of the device. Such a separate axle is susceptible to jamming by the ingress of powder between the contacting surfaces associated with the axle.
- an inhaler for delivering a substance in a finely divided form, comprising a body defining a storage chamber and further defining an inhalation passage through which air is inhaled in use, and a metering member operable to transfer a volumetric dose of the substance from the storage chamber to the inhalation passage, the metering member having a metering surface which is indented to provide at least one dispensing cup and being moveable between a first position in which the dispensing cup is presented to the storage chamber to receive a dose of the substance and a second position in which the dispensing cup is presented to the inhalation passage in a position which is upwardly open in use, the body comprising a seat having an annular contact surface making sliding contact with the metering surface, the contact surface being frusto-conical in shape so as to define a socket within which the metering member is journalled for rotation between the first and second positions.
- biassing means are provided to resiliently bias the metering member into contact with the seat.
- - Fi ⁇ ure 1 is a general perspective view of an inhaler of the invention
- FIG. 1 is a side view of the inhaler in use
- FIG. 3 is a longitudinal section through the inhaler
- FIG. 4 is section IV-IV of Fig. 3; - o -
- Figures 5 and 6 are exploded perspective views of the inhaler viewed from opposite ends;
- FIGS. 7a and 7b are exploded perspective views of the counter mechanism of the inhaler, again viewed from opposite ends;
- FIG. 8a and 8b show the assembled counter mechanism viewed from opposite ends.
- the inhaler comprises a housing 1 which is provided with an air intake 2.
- a tubular mouthpiece 3 projects from the housing.
- the housing contains an internal body 4 which, on its side remote from the mouthpiece 3, contains a recess 5 that provides a seat for a metering member 6 which is rotatable about its axis in the recess.
- the metering member includes a portion having a frusto- conical metering surface 7 which includes a series of circumferentially arranged cup-like metering depressions 8.
- the recess 5 provides a seat of corresponding frusto-conical shape, the angular tolerance and circumferential form of the metering surface and of the seat being carefully monitored in manufacture to ensure a close sliding contact between the two mating faces.
- the opposite side of the body 4 includes a storage chamber 10 for a drug in the form of a micronised powder, the chamber 10 being arranged to register with one of the depressions 8.
- a second, outer chamber 11 surrounds the storage chamber 10 for containing a moisture absorbing material such as silica gel granules.
- the second chamber 11 is open to the depressions 8 on both sides of the depression which is currently in register with the storage chamber 10, but the silica gel is prevented from migrating into the depressions by a shaped filter membrane 12.
- the same side of the body 4 further contains an inhalation passage 15 and a waste chamber 16, both of which register with one of the depressions 8.
- the inhalation passage 15 has a smooth internal contour and registers with both the air inlet 2 and the mouthpiece 3.
- the air inlet 2 contains a filter membrane 17 for removing any contaminating particles that may be drawn into the inlet.
- the waste chamber 16 contains a brush, a piece of sponge rubber or other flexible wiping element 18 which projects into the corresponding depression 8 to make wiping contact with the walls of the depression.
- the inhalation passage 15 when the inhaler is in use, the inhalation passage 15 extends in a downwards direction from the air intake 2, at least to the position where the dispensing cup 8 is presented to the inhalation passage.
- the width of the inhalation passage 15 is relatively large at the air intake, relatively small in the region of the dispensing cup and relatively large again at the mouthpiece 3.
- the inhalation passage includes a first relatively more- inclined portion extending generally downwardly from the air intake 2 to the dispensing cup 8 and a second relatively less-inclined portion extending from the dispensing cup 8 to the mouthpiece 3.
- Dispensing cup 8 is situated on the outside of the bend linking these two portions of the inhalation passage.
- the wall of the inhalation passage bulges across the inhalation passage towards a dispensing cup to create a restricted passageway in the region of the dispensing cup.
- the shape of the inhalation passage results in the air being both accelerated and directed towards the dispensing cup so that there is a highly efficient pick-up of material from the cup.
- the frusto-conical head of the metering member 6 is secured to a co-axial circular ratchet formation 20 followed by a drum 21.
- a spring washer 22 acts between an end face of the drum 21 and the housing 1 to urge the metering member 6 against its seat in the recess 5.
- An indexing button 25 projects from the housing 1 adjacent to the inlet 2 and is secured to an integral indexing finger 26 for engagement with the ratchet formation 20.
- a spring finger 27, again integral with the button 25, projects transversely of the indexing finger 26 to engage the internal body 4 and thus urge the button to project from the housing 1.
- a tape 30 is wound into a roll 31 which is freely rotatable on a pin 32 projecting from the inside of the housing 1.
- the leading end of the tape 30 is secured to the drum 21, onto which it is wound from the roll 30 upon rotation of the metering member 6.
- the tape 30 is routed past a window 33 in the housing 1 through which a contiguous series of numbers or other information carried on the tape is displayed.
- the inhaler will normally be supplied as a sealed unit with the storage chamber 10 pre-filled with medicament or other substance in a dry, finely divided form.
- the button 25 uppermost, the depression 8 which is in register with the storage chamber 10 will fill with a fixed volume of the medicament.
- the mouthpiece 3 is inserted into the mouth as shown in Fig. 2 and the button 25 is depressed using the index finger so that the indexing element 26 causes the metering member 6 to rotate by one position, thus bringing the next, empty depression 8 into register with the storage chamber 10.
- a filled depression comes into register with the inhalation passage 15.
- the internal contours of the inhalation passage causes the air to impinge on the material still held in the depression 8, causing the powder to be mix into the air flow and, after passing through the mouthpiece 3, enter the mouth and air passages of the user.
- the powder in the depression 8 is subjected to the entire airflow through the inhalation passage 15, from the air intake 2 to the mouthpiece 3, which enables the user more readily to achieve a full dose, and also promotes substantially complete removal of the powder from the depression 8.
- the depressions As the depressions travel around the axis of the metering member with successive indexing movements of the button 25, they move past the wiping element 18 so that any residue of powder remaining in the depression is dislodged therefrom to fall into the waste chamber 16. Further travel of the depression causes it to move in register with the drying chamber 11 so that the silica gel can absorb any moisture from the depression before it comes into register with the storage chamber 10 to be refilled with medicament.
- the filled depressions may also move in register with the drying chamber 12 to reduce the possibility of moisture migrating from the inhalation passage 15 to the storage chamber 10. This may additionally ensure that the medicament remains dry, thereby ensuring that the vast majority of the medicament can be easily removed from the depression into the inhaled airflow.
- new information is carried into the window 33 by the tape 30. This information could simply be a number indicating how many doses have been used, or how many remain to be used, or both.
- the window could also display other information such as the time when the next dose should be taken.
- the device will be disposed of once the intended number of doses has been used. It is, however, envisaged that the internal body 4 could contain a replaceable cartridge containing a fresh supply of medicament and possibly also fresh silica gel, new filters 12 and/or 17, and a fresh tape 31. This tape could be partially wound onto a replaceable drum 21 which engages the frusto-conical metering head 6.
- FIGs 7 and 8 A modified counting arrangement is shown in Figs 7 and 8.
- the housing 1 contains a circular internal recess 36 which receives an outer ring 37 and an inner disc 38 which are arranged co-axially with the metering member 6.
- the disc 38 carries the units 0 to 9 at 36° intervals whereas the ring 37 is marked in multiples of tens at regular angular intervals. The tens and units are disposed so that they can both be displayed through a window 39 in the housing 1.
- the disc 38 is connected to, or driven by, the metering member 6 and carries an integral spring arm 40 which carries a pin 41 to act as a cam follower.
- the arm 39 engages a cam 44 secured to the interior of the housing 1, which causes the cam follower 41 to engage in one of a series of notches 45 around the outer periphery of the ring 37.
- This indexes the ring by one angular position on each rotation of the disc 38.
- the number displayed in the window 40 can thus be incremented from, say, 1 to 200 to count the number of doses used.
- a second transparent disc could be disposed behind the disc 38 so that the units are visible through the second disc, which again carries multiples of tens.
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Biophysics (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Anesthesiology (AREA)
- Public Health (AREA)
- Heart & Thoracic Surgery (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Theoretical Computer Science (AREA)
- Physics & Mathematics (AREA)
- General Physics & Mathematics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Medicinal Preparation (AREA)
- Containers And Packaging Bodies Having A Special Means To Remove Contents (AREA)
- Steroid Compounds (AREA)
- External Artificial Organs (AREA)
Abstract
Description
Claims
Priority Applications (12)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BR919106693A BR9106693A (en) | 1990-07-13 | 1991-07-11 | INHALER |
DE69108912T DE69108912T2 (en) | 1990-07-13 | 1991-07-11 | INHALATION DEVICE. |
EP91913462A EP0539469B1 (en) | 1990-07-13 | 1991-07-11 | Inhaler |
KR1019930700026A KR0184288B1 (en) | 1990-07-13 | 1991-07-11 | Powder inhaler having a multi-positioned metering cup |
AU81916/91A AU657914B2 (en) | 1990-07-13 | 1991-07-11 | Inhaler |
JP3512226A JP2891541B2 (en) | 1990-07-13 | 1991-07-11 | Inhaler |
GB9225559A GB2260498B (en) | 1990-07-13 | 1992-12-07 | Inhaler |
NO930084A NO304218B1 (en) | 1990-07-13 | 1993-01-11 | inhaler |
FI930105A FI104236B1 (en) | 1990-07-13 | 1993-01-12 | inhaler |
GR950400986T GR3015854T3 (en) | 1990-07-13 | 1995-04-18 | Inhaler. |
NO982791A NO305467B1 (en) | 1990-07-13 | 1998-06-17 | inhaler |
FI991213A FI105654B (en) | 1990-07-13 | 1999-05-28 | Inhaling device |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9015522.7 | 1990-07-13 | ||
GB909015522A GB9015522D0 (en) | 1990-07-13 | 1990-07-13 | Inhaler |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1992000771A1 true WO1992000771A1 (en) | 1992-01-23 |
Family
ID=10679104
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/GB1991/001147 WO1992000771A1 (en) | 1990-07-13 | 1991-07-11 | Inhaler |
Country Status (18)
Country | Link |
---|---|
US (2) | US5437270A (en) |
EP (2) | EP0573128B1 (en) |
JP (1) | JP2891541B2 (en) |
KR (1) | KR0184288B1 (en) |
AT (2) | ATE120970T1 (en) |
AU (1) | AU657914B2 (en) |
BR (1) | BR9106693A (en) |
CA (1) | CA2086415C (en) |
DE (2) | DE69105756T2 (en) |
DK (2) | DK0539469T3 (en) |
ES (2) | ES2072006T3 (en) |
FI (1) | FI104236B1 (en) |
GB (3) | GB9015522D0 (en) |
GR (2) | GR3015317T3 (en) |
NO (2) | NO304218B1 (en) |
NZ (2) | NZ248398A (en) |
WO (1) | WO1992000771A1 (en) |
ZA (1) | ZA915437B (en) |
Cited By (95)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1993003782A1 (en) * | 1991-08-15 | 1993-03-04 | Bon F Del | Inhaler |
WO1993003785A2 (en) * | 1991-08-26 | 1993-03-04 | Minnesota Mining And Manufacturing Company | Powder dispenser |
WO1993016748A2 (en) * | 1992-02-21 | 1993-09-02 | Innovata Biomed Limited | Metering device |
WO1993021980A1 (en) * | 1992-05-05 | 1993-11-11 | Astra Aktiebolag | Dosage inhalator with indicating/interrupting means |
WO1994006497A1 (en) * | 1992-09-11 | 1994-03-31 | Glaxo Group Limited | Inhalation device |
WO1994013348A1 (en) * | 1992-12-11 | 1994-06-23 | Astra Aktiebolag | Inhaler |
EP0611577A1 (en) * | 1992-11-24 | 1994-08-24 | Bayer Ag | Powder inhalator |
WO1995016483A1 (en) * | 1993-12-18 | 1995-06-22 | Merck Patent Gmbh | Powder inhalator |
EP0661070A1 (en) * | 1993-11-30 | 1995-07-05 | Bayer Ag | Inhalation device |
WO1995017917A1 (en) * | 1993-12-31 | 1995-07-06 | King's College London | Dry powder inhalers |
WO1996008284A2 (en) * | 1994-09-16 | 1996-03-21 | Laboratoire Glaxo Wellcome | Inhalation device |
WO1996008303A1 (en) * | 1994-09-14 | 1996-03-21 | Nippondenso Co., Ltd. | Deodorizing filter |
US5612053A (en) * | 1995-04-07 | 1997-03-18 | Edward Mendell Co., Inc. | Controlled release insufflation carrier for medicaments |
US5622166A (en) * | 1995-04-24 | 1997-04-22 | Dura Pharmaceuticals, Inc. | Dry powder inhaler delivery system |
WO1997017097A1 (en) * | 1995-11-10 | 1997-05-15 | Orion-Yhtymä Oy | Powder inhaler |
WO1998041257A1 (en) * | 1997-03-14 | 1998-09-24 | Astra Aktiebolag | Inhalation device |
US5857457A (en) * | 1994-05-11 | 1999-01-12 | Orion-Yhtyma Oy | Powder inhaler with remnant mover and chamber |
US6029661A (en) * | 1991-08-26 | 2000-02-29 | 3M Innovative Properties Company | Powder dispenser |
US6123070A (en) * | 1996-06-07 | 2000-09-26 | Valois S.A. | Device for enhancing the emptying of an inhaler metering chamber |
US6132394A (en) * | 1994-05-31 | 2000-10-17 | Leiras Oy | Medicament chamber in an inhalation apparatus |
AU730625B2 (en) * | 1994-09-16 | 2001-03-08 | Laboratoire Glaxo Wellcome S.A. | Inhalation device |
WO2001031578A1 (en) * | 1999-10-22 | 2001-05-03 | Innovata Biomed Limited | Mechanical doses counter in a powder inhaler |
WO2001039823A1 (en) * | 1999-12-01 | 2001-06-07 | Innovata Biomed Limited | Inhaler |
WO2001041850A1 (en) * | 1999-12-07 | 2001-06-14 | Orion Corporation | Multidose powder inhaler |
WO2001066334A1 (en) * | 2000-03-04 | 2001-09-13 | Ml Laboratories Plc | Modular mould tools |
WO2002011894A1 (en) | 2000-08-09 | 2002-02-14 | Innovata Biomed Limited | Diaphragm |
WO2002030501A1 (en) | 2000-10-10 | 2002-04-18 | Innovata Biomed Limited | Aerosol production using a frangible diaphragm |
WO2002034320A1 (en) * | 2000-10-27 | 2002-05-02 | Orion Corporation | Dry powder inhaler |
WO2002089882A1 (en) | 2001-05-10 | 2002-11-14 | Ml Laboratories Plc | Gauge |
AU777278B2 (en) * | 1999-06-05 | 2004-10-07 | Innovata Biomed Limited | Delivery system |
WO2005102429A1 (en) * | 2004-04-21 | 2005-11-03 | Innovata Biomed Limited | Inhaler |
EP1616592A1 (en) | 2004-07-16 | 2006-01-18 | Sofotec GmbH & Co. KG | Inhaler for the administration of powdered pharmaceuticals, and a powder cartridge for use with this inhaler |
EP1658872A2 (en) | 2002-07-31 | 2006-05-24 | CHIESI FARMACEUTICI S.p.A. | Powder inhaler |
US7143764B1 (en) | 1998-03-13 | 2006-12-05 | Astrazeneca Ab | Inhalation device |
CN1325129C (en) * | 1995-06-21 | 2007-07-11 | Meda制药有限及两合公司 | Cartrige and medicine powder inhalator with integrated metering device |
EP1891974A1 (en) | 2004-05-31 | 2008-02-27 | Laboratorios Almirall, S.A. | Combinations comprising antimuscarinic agents and PDE4 inhibitors |
EP1891973A1 (en) | 2004-05-31 | 2008-02-27 | Laboratorios Almirall, S.A. | Combinations comprising antimuscarinic agents and PDE4 inhibitors |
US7387122B2 (en) | 2002-10-11 | 2008-06-17 | Otsuka Pharmaceutical Co., Ltd. | Powder inhalator |
EP1941868A2 (en) | 2000-02-28 | 2008-07-09 | PharmaKodex Limited | Improvements in or relating to the delivery of oral drugs |
WO2008107125A1 (en) | 2007-03-02 | 2008-09-12 | Almirall, S.A. | New 3-([1,2,4]triazolo[4,3-a]pyridin-7-yl)benzamide derivatives |
CZ300015B6 (en) * | 1999-04-23 | 2009-01-14 | Innovata Biomed Limited | Powder inhaler for combined medicament |
CZ300028B6 (en) * | 1999-04-23 | 2009-01-14 | Innovata Biomed Limited | Apparatus for dispensing powder medicament by inhalation |
WO2009087404A1 (en) | 2008-01-11 | 2009-07-16 | Innovata Biomed Limited | Improvements in or relating to inhalers |
EP2096105A1 (en) | 2008-02-28 | 2009-09-02 | Laboratorios Almirall, S.A. | Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the b2 adrenergic receptor |
EP2100599A1 (en) | 2008-03-13 | 2009-09-16 | Laboratorios Almirall, S.A. | Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease |
EP2100598A1 (en) | 2008-03-13 | 2009-09-16 | Laboratorios Almirall, S.A. | Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease |
EP2108641A1 (en) | 2008-04-11 | 2009-10-14 | Laboratorios Almirall, S.A. | New substituted spiro[cycloalkyl-1,3'-indo]-2'(1'H)-one derivatives and their use as p38 mitogen-activated kinase inhibitors |
EP2113503A1 (en) | 2008-04-28 | 2009-11-04 | Laboratorios Almirall, S.A. | New substituted indolin-2-one derivatives and their use as p39 mitogen-activated kinase inhibitors |
EP2196465A1 (en) | 2008-12-15 | 2010-06-16 | Almirall, S.A. | (3-oxo)pyridazin-4-ylurea derivatives as PDE4 inhibitors |
WO2010072354A1 (en) | 2008-12-22 | 2010-07-01 | Almirall, S.A. | MESYLATE SALT OF 5-(2-{[6-(2,2-DIFLUORO-2-PHENYLETHOXY)HEXYL]AMINO }-1-HYDROXYETHYL)-8-HYDROXYQUINOLIN-2(1H)-ONE AS AGONIST OF THE β2 ADRENERGIC RECEPTOR |
US7766188B2 (en) | 2005-03-16 | 2010-08-03 | Valois S.A.S. | Dose indicator device for a fluid or powdery product dispenser |
EP2221297A1 (en) | 2009-02-18 | 2010-08-25 | Almirall, S.A. | 5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]amino}-1-hydroxyethyl)-8-hydroxyquinolin-2(1h)-one and its use in the treatment of pulmonary diseases |
EP2221055A1 (en) | 2009-02-18 | 2010-08-25 | Almirall, S.A. | 5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]amino}-1-hydroxyethyl)-8-hydroxyquinolin-2(1H)-one for the treatment of lung function |
WO2010097172A1 (en) | 2009-02-27 | 2010-09-02 | Almirall, S.A. | New tetrahydropyrazolo[3,4-c]isoquinolin-5-amine derivatives |
US7819285B2 (en) | 2004-08-12 | 2010-10-26 | Teijin Pharma Limited | Counter mechanism of feeding device and feeding device using such counter mechanism |
EP2263998A1 (en) | 2005-05-20 | 2010-12-22 | Almirall S.A. | Derivatives of 4-(2-amino-1-hydroxyethyl) phenol as agonists of the beta2 adrenergic receptor |
EP2322176A1 (en) | 2009-11-11 | 2011-05-18 | Almirall, S.A. | New 7-phenyl-[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one derivatives |
EP2380890A1 (en) | 2010-04-23 | 2011-10-26 | Almirall, S.A. | New 7,8-dihydro-1,6-naphthyridin-5(6h)-one-derivatives as PDE4 inhibitors |
EP2386555A1 (en) | 2010-05-13 | 2011-11-16 | Almirall, S.A. | New cyclohexylamine derivatives having beta2 adrenergic agonist and m3 muscarinic antagonist activities |
EP2394998A1 (en) | 2010-05-31 | 2011-12-14 | Almirall, S.A. | 3-(5-Amino-6-oxo-1,6-dihydropyridazin-3-yl)-biphenyl derivatives as PDE4 inhibitors |
WO2012041476A1 (en) | 2010-09-30 | 2012-04-05 | Almirall, S.A. | Pyridine and isoquinoline derivatives as syk- and jak-kinase inhibitors |
US8178679B2 (en) | 2007-11-28 | 2012-05-15 | Almirall, S.A. | Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the β2 adrenergic receptors |
EP2457900A1 (en) | 2010-11-25 | 2012-05-30 | Almirall, S.A. | New pyrazole derivatives having CRTh2 antagonistic behaviour |
WO2012069202A1 (en) | 2010-11-26 | 2012-05-31 | Almirall,S.A. | Imidazo [1,2-b] pyridazine and imidazo [4,5-b] pyridine derivatives as jak inhibitors |
EP2489663A1 (en) | 2011-02-16 | 2012-08-22 | Almirall, S.A. | Compounds as syk kinase inhibitors |
US8283342B2 (en) | 2007-02-09 | 2012-10-09 | Almirall S.A. | Napadisylate salt of 5-(2-{[6-(2,2-difluoro-2-phenylethoxy) hexyl]amino}-1-hydroxyethyl)-8-hydroxyquinolin-2(1H)-one as agonist of the β2 adrenergic receptor |
EP2518071A1 (en) | 2011-04-29 | 2012-10-31 | Almirall, S.A. | Imidazopyridine derivatives as PI3K inhibitors |
EP2518070A1 (en) | 2011-04-29 | 2012-10-31 | Almirall, S.A. | Pyrrolotriazinone derivatives as PI3K inhibitors |
EP2526945A1 (en) | 2011-05-25 | 2012-11-28 | Almirall, S.A. | New CRTH2 Antagonists |
EP2527344A1 (en) | 2011-05-25 | 2012-11-28 | Almirall, S.A. | Pyridin-2(1H)-one derivatives useful as medicaments for the treatment of myeloproliferative disorders, transplant rejection, immune-mediated and inflammatory diseases |
EP2548876A1 (en) | 2011-07-18 | 2013-01-23 | Almirall, S.A. | New CRTh2 antagonists |
EP2548863A1 (en) | 2011-07-18 | 2013-01-23 | Almirall, S.A. | New CRTh2 antagonists. |
EP2554544A1 (en) | 2011-08-01 | 2013-02-06 | Almirall, S.A. | Pyridin-2(1h)-one derivatives as jak inhibitors |
EP2592077A1 (en) | 2011-11-11 | 2013-05-15 | Almirall, S.A. | New cyclohexylamine derivatives having beta2 adrenergic agonist and M3 muscarinic antagonist activities |
EP2592078A1 (en) | 2011-11-11 | 2013-05-15 | Almirall, S.A. | New cyclohexylamine derivatives having beta2 adrenergic agonist and M3 muscarinic antagonist activities |
US8524908B2 (en) | 2009-03-12 | 2013-09-03 | Almirall, S.A. | Process for manufacturing 5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]amino}-1-hydroxyethyl)-8-hydroxyquinolin-2(1H)-one |
EP2641900A1 (en) | 2012-03-20 | 2013-09-25 | Almirall, S.A. | Novel polymorphic Crystal forms of 5-(2-{[6-(2,2-difluoro-2-phenylethoxy) hexyl]amino}-1-(R)-hydroxyethyl)-8-hydroxyquinolin-2(1h)-one, heminapadisylate as agonist of the ß2 adrenergic receptor. |
US8550070B2 (en) | 2001-06-20 | 2013-10-08 | Orion Corporation | Powder inhaler |
EP2647627A1 (en) | 2012-04-02 | 2013-10-09 | Almirall, S.A. | Salts of 5-[(1r)-2-({2-[4-(2,2-difluoro-2-phenylethoxy)phenyl] ethyl}amino)-1-hydroxyethyl]-8-hydroxyquinolin-2(1h)-one. |
US8567394B2 (en) | 2006-12-22 | 2013-10-29 | Almirall, S.A. | Inhalation device for drugs in powder form |
EP2666465A1 (en) | 2012-05-25 | 2013-11-27 | Almirall, S.A. | Novel dosage and formulation |
EP2668941A1 (en) | 2012-05-31 | 2013-12-04 | Almirall, S.A. | Novel dosage form and formulation of abediterol |
WO2014060431A1 (en) | 2012-10-16 | 2014-04-24 | Almirall, S.A. | Pyrrolotriazinone derivatives as pi3k inhibitors |
EP2738172A1 (en) | 2012-11-28 | 2014-06-04 | Almirall, S.A. | New bicyclic compounds as crac channel modulators |
WO2014095920A1 (en) | 2012-12-18 | 2014-06-26 | Almirall, S.A. | New cyclohexyl and quinuclidinyl carbamate derivatives having beta2 adrenergic agonist and m3 muscarinic antagonist activity |
WO2014124757A1 (en) | 2013-02-15 | 2014-08-21 | Almirall, S.A. | Pyrrolotriazine derivatives as pi3k inhibitors |
EP2848615A1 (en) | 2013-07-03 | 2015-03-18 | Almirall, S.A. | New pyrazole derivatives as CRAC channel modulators |
US9056100B2 (en) | 1999-07-14 | 2015-06-16 | Almirall, S.A. | Quinuclidine derivatives and medicinal compositions containing the same |
WO2015091287A1 (en) | 2013-12-19 | 2015-06-25 | Almirall S.A. | Dosage formulation comprising salmeterol and fluticasone propionate |
US9108918B2 (en) | 2011-10-07 | 2015-08-18 | Almirall, S.A. | Process for preparing 5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]amino}-1(R)-hydroxyethyl)-8-hydroxyquinolin-2(1H)-one via a novel intermediate |
WO2016170009A1 (en) | 2015-04-21 | 2016-10-27 | Almirall, S.A. | Amino-substituted heterocyclic derivatives as sodium channel inhibitors |
WO2016202800A1 (en) | 2015-06-16 | 2016-12-22 | Almirall, S.A. | Pyrrolotriazinone derivatives as pi3k inhibitors |
WO2017076990A1 (en) | 2015-11-05 | 2017-05-11 | Almirall, S.A. | Addition salts of n-[4-(4-{[(1s)-1-(5-methyl-4-oxo-3-phenyl-3,4-dihydropyrrolo[2,1-f][1,2,4]triazin-2-yl)ethyl]amino}-7h-pyrrolo[2,3-d]pyrimidin-5-yl)-1h-indol-6-yl]sulfamide |
US9737520B2 (en) | 2011-04-15 | 2017-08-22 | Almirall, S.A. | Aclidinium for use in improving the quality of sleep in respiratory patients |
WO2019030298A1 (en) | 2017-08-08 | 2019-02-14 | Almirall, S.A. | Novel compounds activating the nrf2 pathway |
Families Citing this family (133)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SK280968B6 (en) | 1990-03-02 | 2000-10-09 | Glaxo Group Limited | Medicament pack for use in an inhalation device |
GB9004781D0 (en) * | 1990-03-02 | 1990-04-25 | Glaxo Group Ltd | Device |
YU48707B (en) * | 1990-03-02 | 1999-07-28 | Glaxo Group Limited | Inhalation device |
US6536427B2 (en) | 1990-03-02 | 2003-03-25 | Glaxo Group Limited | Inhalation device |
GB9015522D0 (en) * | 1990-07-13 | 1990-08-29 | Braithwaite Philip W | Inhaler |
PT101450B (en) * | 1994-02-02 | 1999-11-30 | Hovione Produtos Farmaceuticos | NEW INHALATION DEVICE |
WO1995024234A1 (en) * | 1994-03-10 | 1995-09-14 | Bon F Del | Inhalator |
SE9404140D0 (en) * | 1994-11-29 | 1994-11-29 | Astra Ab | Dose indicating device |
EE03997B1 (en) * | 1995-04-14 | 2003-04-15 | Glaxo Wellcome Inc. | Albuterol metered dose inhaler |
RO119117B1 (en) * | 1995-04-14 | 2004-04-30 | Glaxo Wellcome Inc. | Fixed dose inhaler for fluticasone propionate |
FR2738153B1 (en) * | 1995-09-04 | 1998-01-02 | Valois | INHALATION APPARATUS FOR DELIVERING PRECISE AND REPRODUCIBLE DOSES OF POWDERY PRODUCT |
FR2738152B1 (en) * | 1995-09-04 | 1998-01-23 | Tebro | POWDER PRODUCT PREDOSING DEVICE FOR A PRODUCT DISPENSER |
DE19647947A1 (en) * | 1996-11-20 | 1998-05-28 | Pfeiffer Erich Gmbh & Co Kg | Discharge device for media |
GB9626263D0 (en) | 1996-12-18 | 1997-02-05 | Innovata Biomed Ltd | Powder inhaler |
GB2320489A (en) | 1996-12-20 | 1998-06-24 | Norton Healthcare Ltd | Inhaler dose counter |
SE9700936D0 (en) * | 1997-03-14 | 1997-03-14 | Astra Ab | Inhalation device |
SE9700937D0 (en) | 1997-03-14 | 1997-03-14 | Astra Ab | Powder inhales I |
TW469832U (en) | 1997-03-14 | 2001-12-21 | Astra Ab | Inhalation device |
NL1006058C2 (en) * | 1997-05-14 | 1998-11-17 | R & D Injector Ag | Dosing device. |
TW533865U (en) | 1997-06-10 | 2003-05-21 | Glaxo Group Ltd | Dispenser for dispensing medicament and actuation indicating device |
US6142339A (en) | 1998-01-16 | 2000-11-07 | 1263152 Ontario Inc. | Aerosol dispensing device |
EP1047467B1 (en) | 1998-01-16 | 2004-06-23 | 1263152 Ontario Inc. | Indicating device for use with a dispensing device |
US6082358A (en) | 1998-05-05 | 2000-07-04 | 1263152 Ontario Inc. | Indicating device for aerosol container |
US6729330B2 (en) | 1998-05-05 | 2004-05-04 | Trudell Medical International | Indicating device for aerosol container |
US6336453B1 (en) | 1999-04-30 | 2002-01-08 | Trudell Medical International | Indicating device for aerosol container |
DE19831525A1 (en) * | 1998-07-14 | 2000-01-20 | Pfeiffer Erich Gmbh & Co Kg | Media Donor |
US9006175B2 (en) | 1999-06-29 | 2015-04-14 | Mannkind Corporation | Potentiation of glucose elimination |
GB9920839D0 (en) | 1999-09-04 | 1999-11-10 | Innovata Biomed Ltd | Inhaler |
AU7290800A (en) * | 1999-09-17 | 2001-04-24 | Orion Corporation | Moisture protected powder inhaler |
JP2003511107A (en) * | 1999-10-06 | 2003-03-25 | ゴルデマン・ラウル | Dry powder respiratory control inhaler and method of uniformly distributing and mixing dry powder in air |
GB0003197D0 (en) * | 2000-02-11 | 2000-04-05 | Aid Medic Ltd | Improvements in and relating to controlling drug delivery |
FI20000810A0 (en) | 2000-04-06 | 2000-04-06 | Orion Yhtymae Oyj | The powder inhaler |
GB2364649A (en) * | 2000-05-17 | 2002-02-06 | Orion Corp | Inhaler with Dose Counter |
TWI224514B (en) * | 2000-06-23 | 2004-12-01 | Norton Healthcare Ltd | Dose metering system for medicament inhaler |
JP2004512101A (en) * | 2000-10-20 | 2004-04-22 | グラクソ グループ リミテッド | Inhaler |
MXPA03007017A (en) * | 2001-02-06 | 2004-09-13 | Innovata Biomed Ltd | Medicaments. |
GB0111330D0 (en) | 2001-05-10 | 2001-07-04 | Innovata Biomed Ltd | Device |
GB0111336D0 (en) | 2001-05-10 | 2001-07-04 | Innovata Biomed Ltd | Device |
US6745760B2 (en) | 2001-05-15 | 2004-06-08 | Trudell Medical International | Medicament applicator |
US6681768B2 (en) | 2001-06-22 | 2004-01-27 | Sofotec Gmbh & Co. Kg | Powder formulation disintegrating system and method for dry powder inhalers |
AUPR695801A0 (en) * | 2001-08-10 | 2001-09-06 | Caroma Industries Limited | An ultra-low volume gravity flushing toilet |
NZ532673A (en) * | 2001-11-17 | 2008-07-31 | Aventis Pharma Ltd | Package comprising a medicament, a component that gradually releases a gaseous substance and an adsorbent material |
GB0128148D0 (en) | 2001-11-23 | 2002-01-16 | Innovata Biomed Ltd | Assembly |
GB0217199D0 (en) * | 2002-07-25 | 2002-09-04 | Glaxo Group Ltd | Medicament dispenser |
GB0201677D0 (en) | 2002-01-25 | 2002-03-13 | Glaxo Group Ltd | Medicament dispenser |
CA2479751C (en) | 2002-03-20 | 2008-06-03 | Trent Poole | Inhalation apparatus |
US7004164B2 (en) | 2002-03-21 | 2006-02-28 | Trudell Medical International | Indicating device for aerosol container |
US7025205B2 (en) * | 2002-06-26 | 2006-04-11 | Aventis Pharma Limited | Method and packaging for pressurized containers |
JP2005533582A (en) * | 2002-07-25 | 2005-11-10 | グラクソ グループ リミテッド | Drug dispenser |
EP1534367A1 (en) * | 2002-07-25 | 2005-06-01 | Glaxo Group Limited | Medicament dispenser |
GB0217198D0 (en) * | 2002-07-25 | 2002-09-04 | Glaxo Group Ltd | Medicament dispenser |
GB0217196D0 (en) * | 2002-07-25 | 2002-09-04 | Glaxo Group Ltd | Medicament dispenser |
GB0315509D0 (en) * | 2003-07-02 | 2003-08-06 | Meridica Ltd | Dispensing device |
US7621273B2 (en) | 2003-10-28 | 2009-11-24 | Trudell Medical International | Indicating device with warning dosage indicator |
US7100530B2 (en) | 2003-12-15 | 2006-09-05 | Trudell Medical International, Inc. | Dose indicating device |
MXPA06009133A (en) * | 2004-02-16 | 2007-01-26 | Glaxo Group Ltd | Counter for use with a medicament dispenser. |
GB0409197D0 (en) * | 2004-04-24 | 2004-05-26 | Innovata Biomed Ltd | Device |
GB0418278D0 (en) * | 2004-08-16 | 2004-09-15 | Glaxo Group Ltd | Medicament dispenser |
ES2385934T3 (en) | 2004-08-20 | 2012-08-03 | Mannkind Corporation | CATALYSIS OF THE SYNTHESIS OF DICETOPIPERAZINA. |
KR101644250B1 (en) | 2004-08-23 | 2016-07-29 | 맨카인드 코포레이션 | Diketopiperazine salts, diketomorpholine salts or diketodioxane salts for drug delivery |
US7543582B2 (en) | 2004-09-20 | 2009-06-09 | Trudell Medical International | Dose indicating device with display elements attached to container |
WO2006062448A1 (en) * | 2004-12-10 | 2006-06-15 | Ernst Hörlins Ingenjörsbyrå Ab | Dose inhaler with a dose counter |
CA2899340A1 (en) | 2005-01-20 | 2006-07-27 | Trudell Medical International | Dispensing device |
CN100431634C (en) * | 2005-04-04 | 2008-11-12 | 陈庆堂 | Dry powder aerosolizing inhalator |
US8524734B2 (en) | 2005-05-18 | 2013-09-03 | Mpex Pharmaceuticals, Inc. | Aerosolized fluoroquinolones and uses thereof |
MX359219B (en) | 2005-05-18 | 2018-09-19 | Raptor Pharmaceuticals Inc | Aerosolized fluoroquinolones and uses thereof. |
DK1928423T3 (en) | 2005-09-14 | 2016-02-29 | Mannkind Corp | A method for drug formulation based on increasing the affinity of the active substances to the crystalline microparticle surfaces |
US20070068524A1 (en) * | 2005-09-28 | 2007-03-29 | Microdrug Ag | Inhaler for moisture sensitive drugs |
WO2007073302A1 (en) * | 2005-12-23 | 2007-06-28 | Astrazeneca Ab | New device |
US8535714B2 (en) | 2006-01-06 | 2013-09-17 | Acelrx Pharmaceuticals, Inc. | Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain |
US8357114B2 (en) * | 2006-01-06 | 2013-01-22 | Acelrx Pharmaceuticals, Inc. | Drug dispensing device with flexible push rod |
US8865743B2 (en) * | 2006-01-06 | 2014-10-21 | Acelrx Pharmaceuticals, Inc. | Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain |
US9066847B2 (en) * | 2007-01-05 | 2015-06-30 | Aceirx Pharmaceuticals, Inc. | Storage and dispensing devices for administration of oral transmucosal dosage forms |
US8252329B2 (en) * | 2007-01-05 | 2012-08-28 | Acelrx Pharmaceuticals, Inc. | Bioadhesive drug formulations for oral transmucosal delivery |
US8252328B2 (en) * | 2006-01-06 | 2012-08-28 | Acelrx Pharmaceuticals, Inc. | Bioadhesive drug formulations for oral transmucosal delivery |
US8753308B2 (en) | 2006-01-06 | 2014-06-17 | Acelrx Pharmaceuticals, Inc. | Methods for administering small volume oral transmucosal dosage forms using a dispensing device |
US8202535B2 (en) * | 2006-01-06 | 2012-06-19 | Acelrx Pharmaceuticals, Inc. | Small-volume oral transmucosal dosage forms |
US9289583B2 (en) | 2006-01-06 | 2016-03-22 | Acelrx Pharmaceuticals, Inc. | Methods for administering small volume oral transmucosal dosage forms using a dispensing device |
US8039431B2 (en) | 2006-02-22 | 2011-10-18 | Mannkind Corporation | Method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent |
GB0605150D0 (en) * | 2006-03-14 | 2006-04-26 | Glaxo Group Ltd | Counter For Use With A Medicament Dispenser |
US8141550B2 (en) | 2006-08-01 | 2012-03-27 | Trudell Medical International | Dispensing device |
GB0622827D0 (en) | 2006-11-15 | 2006-12-27 | Glaxo Group Ltd | Sheet driver for use in a drug dispenser |
US20100139655A1 (en) * | 2006-11-19 | 2010-06-10 | Aespironics Ltd | Dry-powder inhaler |
EP2173380A4 (en) * | 2007-07-13 | 2011-08-31 | Abbott Biotech Ltd | METHODS AND COMPOSITIONS FOR PULMONARY ADMINISTRATION OF A TNFa INHIBITOR |
WO2009046072A1 (en) * | 2007-10-02 | 2009-04-09 | Baxter International Inc | Dry powder inhaler |
EP2254630A1 (en) * | 2008-02-20 | 2010-12-01 | Boehringer Ingelheim International GmbH | Powder inhalers |
US8082873B2 (en) | 2008-05-05 | 2011-12-27 | Trudell Medical International | Drive mechanism for an indicating device |
US8181591B1 (en) | 2008-05-23 | 2012-05-22 | Trudell Medical International | Domed actuator for indicating device |
AU2009257311B2 (en) | 2008-06-13 | 2014-12-04 | Mannkind Corporation | A dry powder inhaler and system for drug delivery |
US8485180B2 (en) | 2008-06-13 | 2013-07-16 | Mannkind Corporation | Dry powder drug delivery system |
US9364619B2 (en) | 2008-06-20 | 2016-06-14 | Mannkind Corporation | Interactive apparatus and method for real-time profiling of inhalation efforts |
TWI532497B (en) | 2008-08-11 | 2016-05-11 | 曼凱公司 | Use of ultrarapid acting insulin |
CN105520922A (en) | 2008-10-07 | 2016-04-27 | 拉普特制药有限公司 | Aerosol fluoroquinolone formulations for improved pharmacokinetics |
US8629139B2 (en) | 2008-10-07 | 2014-01-14 | Mpex Pharmaceuticals, Inc. | Topical use of Levofloxacin for reducing lung inflammation |
US8596265B2 (en) | 2008-10-22 | 2013-12-03 | Trudell Medical International | Modular aerosol delivery system |
US8945592B2 (en) | 2008-11-21 | 2015-02-03 | Acelrx Pharmaceuticals, Inc. | Sufentanil solid dosage forms comprising oxygen scavengers and methods of using the same |
US8314106B2 (en) | 2008-12-29 | 2012-11-20 | Mannkind Corporation | Substituted diketopiperazine analogs for use as drug delivery agents |
JP5667095B2 (en) | 2009-03-11 | 2015-02-12 | マンカインド コーポレイション | Apparatus, system and method for measuring inhaler resistance |
WO2010107761A1 (en) | 2009-03-18 | 2010-09-23 | Acelrx Pharmaceuticals, Inc. | Improved storage and dispensing devices for administration of oral transmucosal dosage forms |
AU2010249654B2 (en) | 2009-05-18 | 2013-09-19 | Adamis Pharmaceuticals Corporation | Dry powder inhalers |
CA2764505C (en) | 2009-06-12 | 2018-09-25 | Mannkind Corporation | Diketopiperazine microparticles with defined specific surface areas |
EP2473170B1 (en) | 2009-09-04 | 2019-06-19 | Horizon Orphan LLC | Use of aerosolized levofloxacin for treating cystic fibrosis |
WO2011056889A1 (en) | 2009-11-03 | 2011-05-12 | Mannkind Corporation | An apparatus and method for simulating inhalation efforts |
CA2779488A1 (en) | 2009-11-12 | 2011-05-19 | Stc.Unm | Dry powder inhaler with flutter dispersion member |
RU2571331C1 (en) | 2010-06-21 | 2015-12-20 | Маннкайнд Корпорейшн | Systems and methods for dry powder drug delivery |
ES2646748T3 (en) | 2010-12-07 | 2017-12-15 | Respira Therapeutics, Inc. | Dry powder inhaler |
US10092552B2 (en) | 2011-01-31 | 2018-10-09 | Avalyn Pharma Inc. | Aerosol pirfenidone and pyridone analog compounds and uses thereof |
CN105667994B (en) | 2011-04-01 | 2018-04-06 | 曼金德公司 | Blister package for pharmaceutical kit |
WO2012174472A1 (en) | 2011-06-17 | 2012-12-20 | Mannkind Corporation | High capacity diketopiperazine microparticles |
CA2852536A1 (en) | 2011-10-24 | 2013-05-02 | Mannkind Corporation | Methods and compositions for treating pain |
GB2498746A (en) | 2012-01-26 | 2013-07-31 | Innovata Biomed Ltd | Inhaler which locks when empty |
EP2809780B1 (en) | 2012-02-01 | 2018-05-02 | Protalix Ltd. | Dnase i polypeptides, polynucleotides encoding same, methods of producing dnase i and uses thereof in therapy |
US10463815B2 (en) | 2012-02-21 | 2019-11-05 | Respira Therapeutics, Inc. | Inhaler to deliver substances for prophylaxis or prevention of disease or injury caused by the inhalation of biological or chemical agents |
GB2499597A (en) * | 2012-02-21 | 2013-08-28 | Innovata Biomed Ltd | Dry powder inhaler with stepped rotation of metering member |
US9802012B2 (en) | 2012-07-12 | 2017-10-31 | Mannkind Corporation | Dry powder drug delivery system and methods |
US10159644B2 (en) | 2012-10-26 | 2018-12-25 | Mannkind Corporation | Inhalable vaccine compositions and methods |
ES2754388T3 (en) | 2013-03-15 | 2020-04-17 | Mannkind Corp | Compositions and methods of microcrystalline dicetopiperazine |
US9925144B2 (en) | 2013-07-18 | 2018-03-27 | Mannkind Corporation | Heat-stable dry powder pharmaceutical compositions and methods |
US20150044288A1 (en) | 2013-07-31 | 2015-02-12 | Windward Pharma, Inc. | Aerosol tyrosine kinase inhibitor compounds and uses thereof |
EP3030294B1 (en) | 2013-08-05 | 2020-10-07 | MannKind Corporation | Insufflation apparatus |
CA2936330C (en) | 2014-01-10 | 2023-01-03 | Genoa Pharmaceuticals Inc. | Aerosol pirfenidone and pyridone analog compounds and uses thereof |
US10307464B2 (en) | 2014-03-28 | 2019-06-04 | Mannkind Corporation | Use of ultrarapid acting insulin |
US10561806B2 (en) | 2014-10-02 | 2020-02-18 | Mannkind Corporation | Mouthpiece cover for an inhaler |
US20170304459A1 (en) | 2014-10-10 | 2017-10-26 | Alnylam Pharmaceuticals, Inc. | Methods and compositions for inhalation delivery of conjugated oligonucleotide |
AU2015369710B2 (en) | 2014-12-23 | 2020-09-17 | Vertical Pharmaceuticals, Llc | Systems, devices and methods for dispensing oral transmucosal dosage forms |
CN107427650A (en) | 2015-01-14 | 2017-12-01 | 瑞必治公司 | Powder process for dispersing and device |
CA3225148A1 (en) | 2016-05-19 | 2017-11-23 | Mannkind Corporation | Apparatus, system and method for detecting and monitoring inhalations |
KR20220002600A (en) | 2019-04-29 | 2022-01-06 | 인스메드 인코포레이티드 | Dry powder composition of treprostinil prodrug and method of use thereof |
PL4065199T3 (en) | 2019-11-28 | 2024-04-08 | Chiesi Farmaceutici S.P.A. | Electronic module for an inhaler and inhaler assembly comprising the electronic module |
CA3161769A1 (en) * | 2019-11-28 | 2021-06-03 | Chiesi Farmaceutici S.P.A. | Powder inhaler assembly |
WO2022240897A1 (en) | 2021-05-10 | 2022-11-17 | Sepelo Therapeutics, Llc | Pharmaceutical composition comprising delafloxacin for administration into the lung |
WO2023028364A1 (en) | 2021-08-27 | 2023-03-02 | Sepelo Therapeutics, Llc | Targeted compositions and uses therof |
WO2023150747A1 (en) | 2022-02-07 | 2023-08-10 | Insmed Incorporated | Dry powder compositions of bedaquiline and salts and methods of use thereof |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2386313A1 (en) * | 1977-04-07 | 1978-11-03 | Schering Ag | INHALER FOR THE ADMINISTRATION OF MEDICINAL PRODUCTS |
US4274403A (en) * | 1979-08-29 | 1981-06-23 | Struve Roger L | Inhaler |
EP0069715A1 (en) * | 1981-07-08 | 1983-01-12 | Aktiebolaget Draco | Powder inhalator |
WO1986005991A1 (en) * | 1985-04-12 | 1986-10-23 | Aktiebolaget Draco | An indicating means for a dosage dispensing device |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2587215A (en) * | 1949-04-27 | 1952-02-26 | Frank P Priestly | Inhalator |
IT7920688V0 (en) * | 1979-02-05 | 1979-02-05 | Chiesi Paolo Parma | INHALER FOR PULVERULENT MEDICINAL SUBSTANCES, WITH COMBINED DOSER FUNCTION. |
EP0079478A1 (en) * | 1981-11-03 | 1983-05-25 | Miles Laboratories, Inc. | Medicament inhalation device |
US4570630A (en) * | 1983-08-03 | 1986-02-18 | Miles Laboratories, Inc. | Medicament inhalation device |
FR2585563B1 (en) * | 1985-07-30 | 1993-11-12 | Glaxo Group Ltd | DEVICE FOR ADMINISTERING MEDICINES TO PATIENTS |
GB9015522D0 (en) * | 1990-07-13 | 1990-08-29 | Braithwaite Philip W | Inhaler |
-
1990
- 1990-07-13 GB GB909015522A patent/GB9015522D0/en active Pending
-
1991
- 1991-07-11 BR BR919106693A patent/BR9106693A/en unknown
- 1991-07-11 ES ES91913462T patent/ES2072006T3/en not_active Expired - Lifetime
- 1991-07-11 EP EP93202365A patent/EP0573128B1/en not_active Expired - Lifetime
- 1991-07-11 AT AT91913462T patent/ATE120970T1/en not_active IP Right Cessation
- 1991-07-11 AU AU81916/91A patent/AU657914B2/en not_active Expired
- 1991-07-11 ES ES93202365T patent/ES2068041T3/en not_active Expired - Lifetime
- 1991-07-11 DK DK91913462.7T patent/DK0539469T3/en active
- 1991-07-11 EP EP91913462A patent/EP0539469B1/en not_active Expired - Lifetime
- 1991-07-11 AT AT93202365T patent/ATE114981T1/en not_active IP Right Cessation
- 1991-07-11 DK DK93202365.8T patent/DK0573128T3/en active
- 1991-07-11 JP JP3512226A patent/JP2891541B2/en not_active Expired - Lifetime
- 1991-07-11 DE DE69105756T patent/DE69105756T2/en not_active Expired - Lifetime
- 1991-07-11 WO PCT/GB1991/001147 patent/WO1992000771A1/en active IP Right Grant
- 1991-07-11 KR KR1019930700026A patent/KR0184288B1/en not_active IP Right Cessation
- 1991-07-11 DE DE69108912T patent/DE69108912T2/en not_active Expired - Lifetime
- 1991-07-11 CA CA002086415A patent/CA2086415C/en not_active Expired - Lifetime
- 1991-07-12 NZ NZ248398A patent/NZ248398A/en not_active IP Right Cessation
- 1991-07-12 ZA ZA915437A patent/ZA915437B/en unknown
- 1991-07-12 NZ NZ238958A patent/NZ238958A/en not_active IP Right Cessation
-
1992
- 1992-12-07 GB GB9225559A patent/GB2260498B/en not_active Expired - Lifetime
-
1993
- 1993-01-06 US US08/024,721 patent/US5437270A/en not_active Expired - Lifetime
- 1993-01-11 NO NO930084A patent/NO304218B1/en not_active IP Right Cessation
- 1993-01-12 FI FI930105A patent/FI104236B1/en not_active IP Right Cessation
- 1993-06-01 GB GB9311259A patent/GB2265552B/en not_active Expired - Lifetime
-
1995
- 1995-02-03 US US08/383,002 patent/US5657748A/en not_active Expired - Lifetime
- 1995-03-03 GR GR950400495T patent/GR3015317T3/en unknown
- 1995-04-18 GR GR950400986T patent/GR3015854T3/en unknown
-
1998
- 1998-06-17 NO NO982791A patent/NO305467B1/en not_active IP Right Cessation
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2386313A1 (en) * | 1977-04-07 | 1978-11-03 | Schering Ag | INHALER FOR THE ADMINISTRATION OF MEDICINAL PRODUCTS |
US4274403A (en) * | 1979-08-29 | 1981-06-23 | Struve Roger L | Inhaler |
EP0069715A1 (en) * | 1981-07-08 | 1983-01-12 | Aktiebolaget Draco | Powder inhalator |
WO1986005991A1 (en) * | 1985-04-12 | 1986-10-23 | Aktiebolaget Draco | An indicating means for a dosage dispensing device |
Cited By (181)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1993003782A1 (en) * | 1991-08-15 | 1993-03-04 | Bon F Del | Inhaler |
US6029661A (en) * | 1991-08-26 | 2000-02-29 | 3M Innovative Properties Company | Powder dispenser |
WO1993003785A2 (en) * | 1991-08-26 | 1993-03-04 | Minnesota Mining And Manufacturing Company | Powder dispenser |
WO1993003785A3 (en) * | 1991-08-26 | 1993-04-29 | Minnesota Mining & Mfg | Powder dispenser |
US6119688A (en) * | 1991-08-26 | 2000-09-19 | 3M Innovative Properties Company | Powder dispenser |
EP0826386A2 (en) * | 1991-08-26 | 1998-03-04 | Minnesota Mining And Manufacturing Company | Powder dispenser |
EP0826386A3 (en) * | 1991-08-26 | 1998-07-01 | Minnesota Mining And Manufacturing Company | Powder dispenser |
EP0928618A1 (en) | 1992-02-21 | 1999-07-14 | Innovata Biomed Limited | Powder inhaler |
US5778873A (en) * | 1992-02-21 | 1998-07-14 | Innovata Biomed Limited | Metering device for use in transferring a desired volumetric dose of a flowable substance from a storage container |
KR100264805B1 (en) * | 1992-02-21 | 2000-09-01 | 보예즈 알 엔 | Metering device |
GB2278596A (en) * | 1992-02-21 | 1994-12-07 | Innovata Biomed Ltd | Metering device |
WO1993016748A3 (en) * | 1992-02-21 | 1993-12-23 | Innovata Biomed Ltd | Metering device |
GB2278596B (en) * | 1992-02-21 | 1996-05-01 | Innovata Biomed Ltd | Metering device |
WO1993016748A2 (en) * | 1992-02-21 | 1993-09-02 | Innovata Biomed Limited | Metering device |
US5549101A (en) * | 1992-05-05 | 1996-08-27 | Astra Aktiebolag | Dosage inhalator with indicating/interrupting means |
WO1993021980A1 (en) * | 1992-05-05 | 1993-11-11 | Astra Aktiebolag | Dosage inhalator with indicating/interrupting means |
WO1994006497A1 (en) * | 1992-09-11 | 1994-03-31 | Glaxo Group Limited | Inhalation device |
AU677222B2 (en) * | 1992-09-11 | 1997-04-17 | Glaxo Group Limited | Inhalation device |
EP0611577A1 (en) * | 1992-11-24 | 1994-08-24 | Bayer Ag | Powder inhalator |
WO1994013348A1 (en) * | 1992-12-11 | 1994-06-23 | Astra Aktiebolag | Inhaler |
EP0661070A1 (en) * | 1993-11-30 | 1995-07-05 | Bayer Ag | Inhalation device |
US5505196A (en) * | 1993-11-30 | 1996-04-09 | Bayer Aktiengesellschaft | Device for inhalation |
AU687103B2 (en) * | 1993-11-30 | 1998-02-19 | Bayer Aktiengesellschaft | Device for inhalation |
US5769073A (en) * | 1993-12-18 | 1998-06-23 | Merck Patent Gesellschaft Mit Beschrankter Haftung | Powder inhalator |
WO1995016483A1 (en) * | 1993-12-18 | 1995-06-22 | Merck Patent Gmbh | Powder inhalator |
CN1133470C (en) * | 1993-12-18 | 2004-01-07 | 默克专利股份有限公司 | Powder inhalator |
WO1995017917A1 (en) * | 1993-12-31 | 1995-07-06 | King's College London | Dry powder inhalers |
US5975076A (en) * | 1993-12-31 | 1999-11-02 | King's College London | Dry powder inhalers |
US6332461B1 (en) | 1994-05-11 | 2001-12-25 | Orion-Yhtyma Oy | Powder inhaler |
US5857457A (en) * | 1994-05-11 | 1999-01-12 | Orion-Yhtyma Oy | Powder inhaler with remnant mover and chamber |
US6132394A (en) * | 1994-05-31 | 2000-10-17 | Leiras Oy | Medicament chamber in an inhalation apparatus |
WO1996008303A1 (en) * | 1994-09-14 | 1996-03-21 | Nippondenso Co., Ltd. | Deodorizing filter |
WO1996008284A2 (en) * | 1994-09-16 | 1996-03-21 | Laboratoire Glaxo Wellcome | Inhalation device |
AU730625B2 (en) * | 1994-09-16 | 2001-03-08 | Laboratoire Glaxo Wellcome S.A. | Inhalation device |
EP0979661A1 (en) * | 1994-09-16 | 2000-02-16 | Laboratoire Glaxo Wellcome | Inhalation device |
US6484718B1 (en) | 1994-09-16 | 2002-11-26 | Laboratoire Glaxo Wellcome | Inhalation device |
AU710027B2 (en) * | 1994-09-16 | 1999-09-09 | Laboratoire Glaxo Wellcome | Inhalation device |
US6065471A (en) * | 1994-09-16 | 2000-05-23 | Laboratoire Glaxo Wellcome | Inhalation device |
US6220243B1 (en) | 1994-09-16 | 2001-04-24 | Laboratoire Glaxo Wellcome | Inhalation device |
WO1996008284A3 (en) * | 1994-09-16 | 1996-05-30 | Glaxo Wellcome Lab Sa | Inhalation device |
US7172766B2 (en) | 1995-04-07 | 2007-02-06 | Penwest Pharmaceuticals Company | Controlled release insufflation carrier for medicaments |
US5738865A (en) * | 1995-04-07 | 1998-04-14 | Edward Mendell Co., Inc. | Controlled release insufflation carrier for medicaments |
US5612053A (en) * | 1995-04-07 | 1997-03-18 | Edward Mendell Co., Inc. | Controlled release insufflation carrier for medicaments |
US6387394B1 (en) | 1995-04-07 | 2002-05-14 | Penwest Pharmaceuticals Co. | Controlled release insufflation carrier for medicaments |
US5622166A (en) * | 1995-04-24 | 1997-04-22 | Dura Pharmaceuticals, Inc. | Dry powder inhaler delivery system |
CN1325129C (en) * | 1995-06-21 | 2007-07-11 | Meda制药有限及两合公司 | Cartrige and medicine powder inhalator with integrated metering device |
WO1997017097A1 (en) * | 1995-11-10 | 1997-05-15 | Orion-Yhtymä Oy | Powder inhaler |
US6041779A (en) * | 1995-11-10 | 2000-03-28 | Orion Corporation | Powder inhaler |
US6123070A (en) * | 1996-06-07 | 2000-09-26 | Valois S.A. | Device for enhancing the emptying of an inhaler metering chamber |
AU723699B2 (en) * | 1997-03-14 | 2000-09-07 | Astra Aktiebolag | Inhalation device |
US6484717B1 (en) | 1997-03-14 | 2002-11-26 | Astra Aktiebolag | Inhalation device |
WO1998041257A1 (en) * | 1997-03-14 | 1998-09-24 | Astra Aktiebolag | Inhalation device |
US7143764B1 (en) | 1998-03-13 | 2006-12-05 | Astrazeneca Ab | Inhalation device |
CZ300015B6 (en) * | 1999-04-23 | 2009-01-14 | Innovata Biomed Limited | Powder inhaler for combined medicament |
CZ300028B6 (en) * | 1999-04-23 | 2009-01-14 | Innovata Biomed Limited | Apparatus for dispensing powder medicament by inhalation |
AU777278B2 (en) * | 1999-06-05 | 2004-10-07 | Innovata Biomed Limited | Delivery system |
EP1183061B2 (en) † | 1999-06-05 | 2012-10-17 | Innovata Biomed Limited | Medicament delivery system |
US9056100B2 (en) | 1999-07-14 | 2015-06-16 | Almirall, S.A. | Quinuclidine derivatives and medicinal compositions containing the same |
US10588895B2 (en) | 1999-07-14 | 2020-03-17 | Almirall, S.A. | Quinuclidine derivatives and medicinal compositions containing the same |
US10034867B2 (en) | 1999-07-14 | 2018-07-31 | Almirall, S.A. | Quinuclidine derivatives and medicinal compositions containing the same |
US9687478B2 (en) | 1999-07-14 | 2017-06-27 | Almirall, S.A. | Quinuclidine derivatives and medicinal compositions containing the same |
USRE46417E1 (en) | 1999-07-14 | 2017-05-30 | Almirall, S.A. | Quinuclidine derivatives and their use as muscarinic M3 receptor ligands |
US9333195B2 (en) | 1999-07-14 | 2016-05-10 | Almirall, S.A. | Quinuclidine derivatives and medicinal compositions containing the same |
WO2001031578A1 (en) * | 1999-10-22 | 2001-05-03 | Innovata Biomed Limited | Mechanical doses counter in a powder inhaler |
US6845772B2 (en) | 1999-12-01 | 2005-01-25 | Innovata Biomed Limited | Inhaler |
EP1300171A3 (en) * | 1999-12-01 | 2003-08-13 | Innovata Biomed Limited | Inhaler |
WO2001039823A1 (en) * | 1999-12-01 | 2001-06-07 | Innovata Biomed Limited | Inhaler |
WO2001041850A1 (en) * | 1999-12-07 | 2001-06-14 | Orion Corporation | Multidose powder inhaler |
EP1941868A2 (en) | 2000-02-28 | 2008-07-09 | PharmaKodex Limited | Improvements in or relating to the delivery of oral drugs |
WO2001066334A1 (en) * | 2000-03-04 | 2001-09-13 | Ml Laboratories Plc | Modular mould tools |
WO2002011894A1 (en) | 2000-08-09 | 2002-02-14 | Innovata Biomed Limited | Diaphragm |
WO2002030501A1 (en) | 2000-10-10 | 2002-04-18 | Innovata Biomed Limited | Aerosol production using a frangible diaphragm |
US6983748B2 (en) | 2000-10-27 | 2006-01-10 | Orion Corporation | Dry powder inhaler |
WO2002034320A1 (en) * | 2000-10-27 | 2002-05-02 | Orion Corporation | Dry powder inhaler |
WO2002089882A1 (en) | 2001-05-10 | 2002-11-14 | Ml Laboratories Plc | Gauge |
US8550070B2 (en) | 2001-06-20 | 2013-10-08 | Orion Corporation | Powder inhaler |
US7107988B2 (en) | 2002-07-31 | 2006-09-19 | Chiesi Farmaceutici S.P.A. | Powder inhaler |
US7854226B2 (en) | 2002-07-31 | 2010-12-21 | Chiesi Farmaceutici S.P.A. | Powder inhaler |
EP1658872A2 (en) | 2002-07-31 | 2006-05-24 | CHIESI FARMACEUTICI S.p.A. | Powder inhaler |
US8235039B2 (en) | 2002-10-11 | 2012-08-07 | Otsuka Pharmaceutical Co., Ltd. | Powder inhalator |
US7387122B2 (en) | 2002-10-11 | 2008-06-17 | Otsuka Pharmaceutical Co., Ltd. | Powder inhalator |
US8851069B2 (en) | 2004-04-21 | 2014-10-07 | Innovata Biomed Limited | Inhaler |
WO2005102429A1 (en) * | 2004-04-21 | 2005-11-03 | Innovata Biomed Limited | Inhaler |
EP2002845A2 (en) | 2004-05-31 | 2008-12-17 | Laboratorios Almirall, S.A. | Combinations comprising antimuscarinic agents and corticosteroids |
EP2319538A2 (en) | 2004-05-31 | 2011-05-11 | Almirall S.A. | Combinations combrising antimuscarinic agents and corticosteroids |
EP2002843A2 (en) | 2004-05-31 | 2008-12-17 | Laboratorios Almirall, S.A. | Combinations comprising antimuscarinic agents and beta-adrenergic agonists |
EP2138188A1 (en) | 2004-05-31 | 2009-12-30 | Almirall, S.A. | Combinations comprising antimuscarinic agents and beta-adrenergic agonists |
EP1891974A1 (en) | 2004-05-31 | 2008-02-27 | Laboratorios Almirall, S.A. | Combinations comprising antimuscarinic agents and PDE4 inhibitors |
EP2774623A1 (en) | 2004-05-31 | 2014-09-10 | Almirall S.A. | Combinations comprising antimuscarinic agents and beta-adrenergic agonists |
EP1891973A1 (en) | 2004-05-31 | 2008-02-27 | Laboratorios Almirall, S.A. | Combinations comprising antimuscarinic agents and PDE4 inhibitors |
EP2002844A2 (en) | 2004-05-31 | 2008-12-17 | Laboratorios Almirall, S.A. | Combinations comprising antimuscarininc agents and beta-adrenergic agonists |
EP2292267A2 (en) | 2004-05-31 | 2011-03-09 | Almirall S.A. | Combinations comprising antimuscarinic agents and beta-adrenergic agonists |
EP1905451A1 (en) | 2004-05-31 | 2008-04-02 | Laboratorios Almirall, S.A. | Combinations comprising antimuscarinic agents and corticosteroids |
EP2774622A1 (en) | 2004-05-31 | 2014-09-10 | Almirall, S.A. | Combinations comprising antimuscarinic agents and beta-adrenergic agonists |
US8051851B2 (en) | 2004-07-16 | 2011-11-08 | Sofotec Gmbh & Co. Kg | Inhaler for the administration of powdered pharmaceuticals, and a powder cartridge system for use with this inhaler |
EP1616592A1 (en) | 2004-07-16 | 2006-01-18 | Sofotec GmbH & Co. KG | Inhaler for the administration of powdered pharmaceuticals, and a powder cartridge for use with this inhaler |
US7819285B2 (en) | 2004-08-12 | 2010-10-26 | Teijin Pharma Limited | Counter mechanism of feeding device and feeding device using such counter mechanism |
US7766188B2 (en) | 2005-03-16 | 2010-08-03 | Valois S.A.S. | Dose indicator device for a fluid or powdery product dispenser |
US8420669B2 (en) | 2005-05-20 | 2013-04-16 | Laboratories Almirall, S.A. | Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the BETA2 adrenergic receptor |
EP2263998A1 (en) | 2005-05-20 | 2010-12-22 | Almirall S.A. | Derivatives of 4-(2-amino-1-hydroxyethyl) phenol as agonists of the beta2 adrenergic receptor |
US7964615B2 (en) | 2005-05-20 | 2011-06-21 | Almirall, S.A. | Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the β2 adrenergic receptor |
US8242177B2 (en) | 2005-05-20 | 2012-08-14 | Almirall, S.A. | Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the β2 adrenergic receptor |
US8567394B2 (en) | 2006-12-22 | 2013-10-29 | Almirall, S.A. | Inhalation device for drugs in powder form |
US8283342B2 (en) | 2007-02-09 | 2012-10-09 | Almirall S.A. | Napadisylate salt of 5-(2-{[6-(2,2-difluoro-2-phenylethoxy) hexyl]amino}-1-hydroxyethyl)-8-hydroxyquinolin-2(1H)-one as agonist of the β2 adrenergic receptor |
WO2008107125A1 (en) | 2007-03-02 | 2008-09-12 | Almirall, S.A. | New 3-([1,2,4]triazolo[4,3-a]pyridin-7-yl)benzamide derivatives |
US8178679B2 (en) | 2007-11-28 | 2012-05-15 | Almirall, S.A. | Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the β2 adrenergic receptors |
WO2009087404A1 (en) | 2008-01-11 | 2009-07-16 | Innovata Biomed Limited | Improvements in or relating to inhalers |
EP2096105A1 (en) | 2008-02-28 | 2009-09-02 | Laboratorios Almirall, S.A. | Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the b2 adrenergic receptor |
EP2100598A1 (en) | 2008-03-13 | 2009-09-16 | Laboratorios Almirall, S.A. | Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease |
US11000517B2 (en) | 2008-03-13 | 2021-05-11 | Almirall, S.A. | Dosage and formulation |
EP2946769A1 (en) | 2008-03-13 | 2015-11-25 | Almirall, S.A. | Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease |
US10085974B2 (en) | 2008-03-13 | 2018-10-02 | Almirall, S.A. | Dosage and formulation |
EP2946768A1 (en) | 2008-03-13 | 2015-11-25 | Almirall, S.A. | Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease |
EP2954890A1 (en) | 2008-03-13 | 2015-12-16 | Almirall, S.A. | Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease |
EP2100599A1 (en) | 2008-03-13 | 2009-09-16 | Laboratorios Almirall, S.A. | Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease |
EP2954889A1 (en) | 2008-03-13 | 2015-12-16 | Almirall, S.A. | Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease |
US9254262B2 (en) | 2008-03-13 | 2016-02-09 | Almirall, S.A. | Dosage and formulation |
EP2954891A1 (en) | 2008-03-13 | 2015-12-16 | Almirall, S.A. | Inhalation composition containing aclidinium for treatment of asthma |
EP2108641A1 (en) | 2008-04-11 | 2009-10-14 | Laboratorios Almirall, S.A. | New substituted spiro[cycloalkyl-1,3'-indo]-2'(1'H)-one derivatives and their use as p38 mitogen-activated kinase inhibitors |
EP2113503A1 (en) | 2008-04-28 | 2009-11-04 | Laboratorios Almirall, S.A. | New substituted indolin-2-one derivatives and their use as p39 mitogen-activated kinase inhibitors |
EP2196465A1 (en) | 2008-12-15 | 2010-06-16 | Almirall, S.A. | (3-oxo)pyridazin-4-ylurea derivatives as PDE4 inhibitors |
WO2010072354A1 (en) | 2008-12-22 | 2010-07-01 | Almirall, S.A. | MESYLATE SALT OF 5-(2-{[6-(2,2-DIFLUORO-2-PHENYLETHOXY)HEXYL]AMINO }-1-HYDROXYETHYL)-8-HYDROXYQUINOLIN-2(1H)-ONE AS AGONIST OF THE β2 ADRENERGIC RECEPTOR |
US8563731B2 (en) | 2008-12-22 | 2013-10-22 | Almirall, S.A. | Mesylate salt of 5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]jamino}-1-hydroxyethyl)-8-hydroxyquinolin-2(1H)-one as agonist of the β2 adrenergic receptor |
EP2221297A1 (en) | 2009-02-18 | 2010-08-25 | Almirall, S.A. | 5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]amino}-1-hydroxyethyl)-8-hydroxyquinolin-2(1h)-one and its use in the treatment of pulmonary diseases |
WO2010094484A1 (en) | 2009-02-18 | 2010-08-26 | Almirall, S.A. | 5- (2-{ [6- (2, 2-difluoro-2-phenylethoxy) hexyl] amino}-l-hydroxyethyl) -8-hydroxyquin olin-2 (1h)-one and its use in the treatment of pulmonary diseases |
WO2010094483A1 (en) | 2009-02-18 | 2010-08-26 | Almirall, S.A. | 5- (2-{ [6- (2, 2-difluoro-2-phenylethoxy) hexyl] amino} -1-hydroxyethyl) -8-hydroxyquinolin-2 (ih)-one for the treatment of lung function |
EP2221055A1 (en) | 2009-02-18 | 2010-08-25 | Almirall, S.A. | 5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]amino}-1-hydroxyethyl)-8-hydroxyquinolin-2(1H)-one for the treatment of lung function |
EP2226323A1 (en) | 2009-02-27 | 2010-09-08 | Almirall, S.A. | New tetrahydropyrazolo[3,4-c]isoquinolin-5-amine derivatives |
WO2010097172A1 (en) | 2009-02-27 | 2010-09-02 | Almirall, S.A. | New tetrahydropyrazolo[3,4-c]isoquinolin-5-amine derivatives |
US8524908B2 (en) | 2009-03-12 | 2013-09-03 | Almirall, S.A. | Process for manufacturing 5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]amino}-1-hydroxyethyl)-8-hydroxyquinolin-2(1H)-one |
WO2011057757A1 (en) | 2009-11-11 | 2011-05-19 | Almirall, S.A. | New 7-phenyl-[1,2,4]triazolo[4,3-a]pyridin-3(2h)-one derivatives |
EP2322176A1 (en) | 2009-11-11 | 2011-05-18 | Almirall, S.A. | New 7-phenyl-[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one derivatives |
EP2380890A1 (en) | 2010-04-23 | 2011-10-26 | Almirall, S.A. | New 7,8-dihydro-1,6-naphthyridin-5(6h)-one-derivatives as PDE4 inhibitors |
EP2386555A1 (en) | 2010-05-13 | 2011-11-16 | Almirall, S.A. | New cyclohexylamine derivatives having beta2 adrenergic agonist and m3 muscarinic antagonist activities |
WO2011141180A1 (en) | 2010-05-13 | 2011-11-17 | Almirall, S.A. | NEW CYCLOHEXYLAMINE DERIVATIVES HAVING β2 ADRENERGIC AGONIST AND M3 MUSCARINIC ANTAGONIST ACTIVITIES |
EP2394998A1 (en) | 2010-05-31 | 2011-12-14 | Almirall, S.A. | 3-(5-Amino-6-oxo-1,6-dihydropyridazin-3-yl)-biphenyl derivatives as PDE4 inhibitors |
WO2012041476A1 (en) | 2010-09-30 | 2012-04-05 | Almirall, S.A. | Pyridine and isoquinoline derivatives as syk- and jak-kinase inhibitors |
EP2441755A1 (en) | 2010-09-30 | 2012-04-18 | Almirall, S.A. | Pyridine- and isoquinoline-derivatives as Syk and JAK kinase inhibitors |
WO2012069175A1 (en) | 2010-11-25 | 2012-05-31 | Almirall, S.A. | New pyrazole derivatives having crth2 antagonistic behaviour |
EP2457900A1 (en) | 2010-11-25 | 2012-05-30 | Almirall, S.A. | New pyrazole derivatives having CRTh2 antagonistic behaviour |
EP2463289A1 (en) | 2010-11-26 | 2012-06-13 | Almirall, S.A. | Imidazo[1,2-b]pyridazine derivatives as JAK inhibitors |
WO2012069202A1 (en) | 2010-11-26 | 2012-05-31 | Almirall,S.A. | Imidazo [1,2-b] pyridazine and imidazo [4,5-b] pyridine derivatives as jak inhibitors |
EP2489663A1 (en) | 2011-02-16 | 2012-08-22 | Almirall, S.A. | Compounds as syk kinase inhibitors |
US9737520B2 (en) | 2011-04-15 | 2017-08-22 | Almirall, S.A. | Aclidinium for use in improving the quality of sleep in respiratory patients |
EP2518071A1 (en) | 2011-04-29 | 2012-10-31 | Almirall, S.A. | Imidazopyridine derivatives as PI3K inhibitors |
EP2518070A1 (en) | 2011-04-29 | 2012-10-31 | Almirall, S.A. | Pyrrolotriazinone derivatives as PI3K inhibitors |
WO2012146667A1 (en) | 2011-04-29 | 2012-11-01 | Almirall, S.A. | Imidazopyridine derivatives as pi3k inhibitors |
EP2526945A1 (en) | 2011-05-25 | 2012-11-28 | Almirall, S.A. | New CRTH2 Antagonists |
EP2527344A1 (en) | 2011-05-25 | 2012-11-28 | Almirall, S.A. | Pyridin-2(1H)-one derivatives useful as medicaments for the treatment of myeloproliferative disorders, transplant rejection, immune-mediated and inflammatory diseases |
WO2012160030A1 (en) | 2011-05-25 | 2012-11-29 | Almirall, S.A. | Pyridin-2 (1h) -one derivatives useful as medicaments for the treatment of myeloproliferative disorders, transplant rejection, immune-mediated and inflammatory diseases |
WO2013010881A1 (en) | 2011-07-18 | 2013-01-24 | Almirall, S.A. | NEW CRTh2 ANTAGONISTS |
WO2013010880A1 (en) | 2011-07-18 | 2013-01-24 | Almirall, S.A. | New crth2 antagonists |
EP2548863A1 (en) | 2011-07-18 | 2013-01-23 | Almirall, S.A. | New CRTh2 antagonists. |
EP2548876A1 (en) | 2011-07-18 | 2013-01-23 | Almirall, S.A. | New CRTh2 antagonists |
EP2554544A1 (en) | 2011-08-01 | 2013-02-06 | Almirall, S.A. | Pyridin-2(1h)-one derivatives as jak inhibitors |
WO2013017461A1 (en) | 2011-08-01 | 2013-02-07 | Almirall, S.A. | Pyridin-2(1h)-one derivatives as jak inhibitors |
US9108918B2 (en) | 2011-10-07 | 2015-08-18 | Almirall, S.A. | Process for preparing 5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]amino}-1(R)-hydroxyethyl)-8-hydroxyquinolin-2(1H)-one via a novel intermediate |
WO2013068554A1 (en) | 2011-11-11 | 2013-05-16 | Almirall, S.A. | New cyclohexylamine derivatives having beta 2 adrenergic agonist and m3 muscarinic antagonist activities |
EP2592077A1 (en) | 2011-11-11 | 2013-05-15 | Almirall, S.A. | New cyclohexylamine derivatives having beta2 adrenergic agonist and M3 muscarinic antagonist activities |
EP2592078A1 (en) | 2011-11-11 | 2013-05-15 | Almirall, S.A. | New cyclohexylamine derivatives having beta2 adrenergic agonist and M3 muscarinic antagonist activities |
WO2013068552A1 (en) | 2011-11-11 | 2013-05-16 | Almirall, S.A. | NEW CYCLOHEXYLAMINE DERIVATIVES HAVING β2 ADRENERGIC AGONIST AND M3 MUSCARINIC ANTAGONIST ACTIVITIES |
US9346759B2 (en) | 2012-03-20 | 2016-05-24 | Almirall, S.A. | Polymorphic crystal forms of 5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]amino}-1-(R)-hydroxyethyl)-8-hydroxyquinolin-2(1H)-one, heminapadisytlate as agonist of the β2 adrenergic receptor |
EP2641900A1 (en) | 2012-03-20 | 2013-09-25 | Almirall, S.A. | Novel polymorphic Crystal forms of 5-(2-{[6-(2,2-difluoro-2-phenylethoxy) hexyl]amino}-1-(R)-hydroxyethyl)-8-hydroxyquinolin-2(1h)-one, heminapadisylate as agonist of the ß2 adrenergic receptor. |
WO2013139712A1 (en) | 2012-03-20 | 2013-09-26 | Almirall, S.A. | NOVEL POLYMORPHIC CRYSTAL FORMS OF 5-(2-{[6-(2,2-DIFLUORO-2-PHENYLETHOXY)HEXYL]AMINO}-1-(R)-HYDROXYETHYL)-8-HYDROXYQUINOLIN-2(1H)-ONE, HEMINAPADISYLATE AS AGONIST OF THE β2 ADRENERGIC RECEPTOR. |
EP2647627A1 (en) | 2012-04-02 | 2013-10-09 | Almirall, S.A. | Salts of 5-[(1r)-2-({2-[4-(2,2-difluoro-2-phenylethoxy)phenyl] ethyl}amino)-1-hydroxyethyl]-8-hydroxyquinolin-2(1h)-one. |
WO2013149959A1 (en) | 2012-04-02 | 2013-10-10 | Almirall, S.A. | Salts of 5-[(1r)-2-({2-[4-(2,2-difluoro-2-phenylethoxy)phenyl]ethyl}amino)-1-hydroxyethyl]-8-hydroxyquinolin-2(1h)-one |
EP2666465A1 (en) | 2012-05-25 | 2013-11-27 | Almirall, S.A. | Novel dosage and formulation |
WO2013175013A1 (en) | 2012-05-25 | 2013-11-28 | Almirall, S.A. | Novel dosage and formulation |
WO2013178742A1 (en) | 2012-05-31 | 2013-12-05 | Almirall, S.A. | Novel dosage form and formulation of abediterol |
EP2668941A1 (en) | 2012-05-31 | 2013-12-04 | Almirall, S.A. | Novel dosage form and formulation of abediterol |
WO2014060431A1 (en) | 2012-10-16 | 2014-04-24 | Almirall, S.A. | Pyrrolotriazinone derivatives as pi3k inhibitors |
EP2738172A1 (en) | 2012-11-28 | 2014-06-04 | Almirall, S.A. | New bicyclic compounds as crac channel modulators |
WO2014095920A1 (en) | 2012-12-18 | 2014-06-26 | Almirall, S.A. | New cyclohexyl and quinuclidinyl carbamate derivatives having beta2 adrenergic agonist and m3 muscarinic antagonist activity |
WO2014124757A1 (en) | 2013-02-15 | 2014-08-21 | Almirall, S.A. | Pyrrolotriazine derivatives as pi3k inhibitors |
EP2848615A1 (en) | 2013-07-03 | 2015-03-18 | Almirall, S.A. | New pyrazole derivatives as CRAC channel modulators |
WO2015091285A1 (en) | 2013-12-19 | 2015-06-25 | Almirall S.A. | Dosage formulation comprising salmeterol and fluticasone propionate |
WO2015091287A1 (en) | 2013-12-19 | 2015-06-25 | Almirall S.A. | Dosage formulation comprising salmeterol and fluticasone propionate |
WO2016170009A1 (en) | 2015-04-21 | 2016-10-27 | Almirall, S.A. | Amino-substituted heterocyclic derivatives as sodium channel inhibitors |
WO2016202800A1 (en) | 2015-06-16 | 2016-12-22 | Almirall, S.A. | Pyrrolotriazinone derivatives as pi3k inhibitors |
WO2017076990A1 (en) | 2015-11-05 | 2017-05-11 | Almirall, S.A. | Addition salts of n-[4-(4-{[(1s)-1-(5-methyl-4-oxo-3-phenyl-3,4-dihydropyrrolo[2,1-f][1,2,4]triazin-2-yl)ethyl]amino}-7h-pyrrolo[2,3-d]pyrimidin-5-yl)-1h-indol-6-yl]sulfamide |
WO2019030298A1 (en) | 2017-08-08 | 2019-02-14 | Almirall, S.A. | Novel compounds activating the nrf2 pathway |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU657914B2 (en) | Inhaler | |
JP4629947B2 (en) | Inhalation device with administration frequency counter | |
KR100244690B1 (en) | Device and method for dispensing powdered medicine in multiple doses | |
KR100976304B1 (en) | Powder Inhaler | |
US5243970A (en) | Dosing device for administering metered amounts of powdered medicaments to patients | |
PT626869E (en) | MEDICAL DEVICE | |
AU2001260379A1 (en) | Inhaler with a dose counter | |
JPH10509628A (en) | Dose display | |
WO1995006491A2 (en) | Controlled multi-pharmaceutical inhaler | |
HU225186B1 (en) | Powder inhaler for combined medicament | |
CA2558566A1 (en) | Unit dose dry powder inhaler | |
JP2003516200A (en) | Multi-dose powder inhaler | |
FI105654B (en) | Inhaling device | |
JPH05505544A (en) | Device for measuring the dose of powdered drugs for inhalation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AT AU BB BG BR CA CH DE DK ES FI GB HU JP KP KR LK LU MC MG MW NL NO PL RO SD SE SU US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE BF BJ CF CG CH CI CM DE DK ES FR GA GB GN GR IT LU ML MR NL SE SN TD TG |
|
WWE | Wipo information: entry into national phase |
Ref document number: 9225559.5 Country of ref document: GB |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2086415 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 08024721 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1991913462 Country of ref document: EP Ref document number: 930105 Country of ref document: FI |
|
WWP | Wipo information: published in national office |
Ref document number: 1991913462 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWG | Wipo information: grant in national office |
Ref document number: 1991913462 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 991213 Country of ref document: FI |
|
WWG | Wipo information: grant in national office |
Ref document number: 930105 Country of ref document: FI |
|
WWG | Wipo information: grant in national office |
Ref document number: 991213 Country of ref document: FI |